Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism.

Two novel nitric oxide (NO)-releasing oxatriazole derivatives, GEA 3162 and GEA 3175, and an earlier known NO donor, S-nitroso-N-acetylpenicillamine (SNAP), inhibited cell proliferation and enhanced cGMP production in a concentration-dependent manner in human lymphocytes activated by lectin mitogen concanavalin A (ConA). The possible mediator role of cGMP in the antiproliferative action of NO donors was tested by pharmacological means. An inhibitor of guanylate cyclase, 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one, inhibited NO donor-induced cGMP production, whereas the antiproliferative action of NO donors remained unaltered. Phosphodiesterase inhibitors zaprinast and 3-isobutyl-1-methylxanthine potentiated and prolonged NO donor-induced increase in the concentrations of cGMP but did not enhance the antiproliferative action of NO donors. In addition, two analogs of cGMP, 8-bromo-cGMP and a more cell-permeable compound, 8-p-chlorophenylthio-cGMP, did not inhibit ConA-stimulated lymphocyte proliferation when used in concentrations of up to 300 microM. At millimolar concentrations, 8-bromo-cGMP had a moderate inhibitory action. These results suggest that nitric oxide-releasing oxatriazole derivatives inhibit proliferative responses in human lymphocytes by a cGMP-independent manner.

[1]  E. Moilanen,et al.  Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. , 1997, European journal of pharmacology.

[2]  T. Shimizu,et al.  Further study on the roles of the effector molecules of immunosuppressive macrophages induced by mycobacterial infection in expression of their suppressor function against mitogen‐stimulated T cell proliferation , 1997, Clinical and experimental immunology.

[3]  I. Charles,et al.  Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. , 1997, The American journal of pathology.

[4]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[5]  M. Luomala,et al.  Inhibition by fenamates of calcium influx and proliferation of human lymphocytes , 1996, British journal of pharmacology.

[6]  B. Chain,et al.  Is there a role for nitric oxide in regulation of T cell secretion of IL-2? , 1996, Journal of immunology.

[7]  E. Moilanen,et al.  Nitric oxide‐donating properties of mesoionic 3‐aryl substituted oxatriazole‐5‐imine derivatives , 1996, British journal of pharmacology.

[8]  L. Monnier,et al.  Enhanced antiproliferative effect of nitric oxide in cultured smooth muscle cells from diabetic rats. , 1996, Journal of cardiovascular pharmacology.

[9]  S. Moncada,et al.  Molecular mechanisms and therapeutic strategies related to nitric oxide , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  L. Ignarro,et al.  Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. , 1995, International journal of cardiology.

[11]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[12]  J. Garthwaite,et al.  Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. , 1995, Molecular pharmacology.

[13]  H. Vapaatalo,et al.  Nitric oxide in inflammation and immune response. , 1995, Annals of medicine.

[14]  T. Järvinen,et al.  Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage , 1995, Mediators of inflammation.

[15]  D. Lysle,et al.  Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. , 1995, The Journal of pharmacology and experimental therapeutics.

[16]  T. Lincoln,et al.  cGMP signaling through cAMP- and cGMP-dependent protein kinases. , 1995, Advances in pharmacology.

[17]  M. Karp,et al.  Nitric oxide donor-mediated killing of bioluminescent Escherichia coli , 1994, Antimicrobial Agents and Chemotherapy.

[18]  R. Gryglewski,et al.  Mesoionic oxatriazole derivatives--a new group of NO-donors. , 1994, Polish journal of pharmacology.

[19]  H. Vapaatalo,et al.  Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. , 1994, Polish journal of pharmacology.

[20]  Christopher Y. Lu,et al.  Inhibition of macrophage Ia expression by nitric oxide. , 1994, Journal of immunology.

[21]  J. Ando,et al.  Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. , 1994, Biochemical and biophysical research communications.

[22]  P. Lagadec,et al.  Nitric oxide involvement in tumor-induced immunosuppression. , 1994, Journal of immunology.

[23]  T. Nikkari,et al.  Nitric oxide donor GEA 3162 inhibits endothelial cell‐mediated oxidation of low density lipoprotein , 1994, FEBS letters.

[24]  J. M. Mansfield,et al.  Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. , 1993, Journal of immunology.

[25]  M. Feelisch.  Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. , 1993, European heart journal.

[26]  S. Abramson,et al.  Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. , 1993, Arthritis and rheumatism.

[27]  H. Vapaatalo,et al.  Inhibition by nitric oxide‐donors of human polymorphonuclear leucocyte functions , 1993, British journal of pharmacology.

[28]  J. Albina,et al.  Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. , 1991, Journal of immunology.

[29]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[30]  T. Billiar,et al.  Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. , 1991, The American journal of physiology.

[31]  C. Mills.  Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. , 1991, Journal of immunology.

[32]  L. Ignarro.  Signal transduction mechanisms involving nitric oxide. , 1991, Biochemical pharmacology.

[33]  J. Tenu,et al.  Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. , 1990, The Journal of biological chemistry.

[34]  P. Hersey,et al.  Augmentation of lymphocyte responses by monoclonal antibodies to the gangliosides GD3 and GD2: the role of protein kinase C, cyclic nucleotides, and intracellular calcium. , 1989, Cellular immunology.

[35]  R. Busse,et al.  LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. , 1988, The Journal of pharmacology and experimental therapeutics.

[36]  M. Tjörnhammar,et al.  Cyclic GMP efflux from liver slices. , 1983, The Journal of biological chemistry.

[37]  D. Sachs,et al.  Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. , 1978, Journal of immunology.

[38]  R. Butcher,et al.  Some Aspects of the Biological Role of Adenosine 3′,5′‐monophosphate (Cyclic AMP) , 1968 .